| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Unit of Diabetes, Endocrinology, and Nutrition, Hospital of Girona Dr. Josep Trueta, 17007 Girona, Spain
Address all correspondence and requests for reprints to: J. M. Fernandez-Real, M.D., Ph.D., Unit of Diabetes, Endocrinology, and Nutrition, Hospital de Girona Dr. Josep Trueta, Ctra. França s/n, 17007 Girona, Spain. E-mail: uden.jmfernandezreal{at}htrueta.scs.es.
Context: Levels of TSH respond to fluctuations in serum free T4 (fT4) but remain in a very narrow individual range. There exists current controversy regarding the upper limit of normal serum TSH values above which treatment should be indicated.
Objective: We aimed to study whether the individually determined fT4-TSH relationship was associated with plasma lipids, insulin sensitivity, and endothelial dysfunction in healthy subjects with strictly normal thyroid function according to recent recommendations (0.33.0 mU/liter).
Design: This was a cross-sectional study.
Setting: The study consisted of a cohort of healthy men from the general population (n = 221).
Main Outcome Measures: Oral glucose tolerance, insulin sensitivity (SI, minimal model), endothelium-dependent vasodilation (high-resolution ultrasound), and plasma lipids were measured in relation to thyroid function tests.
Results: Both serum TSH and fT4·TSH product were positively associated with fasting and postload insulin concentration and negatively with SI. After body mass index stratification, these associations were especially significant among lean subjects. Serum TSH and fT4·TSH product also correlated positively with fasting triglycerides and negatively with high-density lipoprotein cholesterol. In a multiple linear regression analysis, age (P = 0.007) and SI (P = 0.02) but not body mass index, fasting triglycerides, or serum high-density lipoprotein concentration contributed independently to 3.7 and 3.3%, respectively, of the variance in fT4·TSH. Those subjects over the median of fT4·TSH showed reduced endothelium-dependent vasodilation.
Conclusions: Thyroid function tests are intrinsically linked to variables of insulin resistance and endothelial function. It is possible that underlying factors lead simultaneously to increased serum TSH, insulin resistance, ensuing dyslipidemia, and altered endothelial function even within current normal TSH levels.
This article has been cited by other articles:
![]() |
H. Volzke, D. M. Robinson, T. Spielhagen, M. Nauck, A. Obst, R. Ewert, B. Wolff, H. Wallaschofski, S. B. Felix, and M. Dorr Are serum thyrotropin levels within the reference range associated with endothelial function? Eur. Heart J., January 2, 2009; 30(2): 217 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Korada, M S Pearce, M P Ward Platt, E Avis, S Turner, H Wastell, and T Cheetham Repeat testing for congenital hypothyroidism in preterm infants is unnecessary with an appropriate thyroid stimulating hormone threshold Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2008; 93(4): F286 - F288. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Asvold, T. Bjoro, T. I. L. Nilsen, D. Gunnell, and L. J. Vatten Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study Arch Intern Med, April 28, 2008; 168(8): 855 - 860. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |